NCT00908271 Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00907075 Pilot Study to Assess Adherence to a Novel Eating System in Men and Women With Type 2 Diabetes Mellitus Status COMPLETED Phase NA
NCT00905528 TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT00904176 Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00902161 A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00901979 A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE2
NCT00899470 Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A) Status COMPLETED Phase PHASE1
NCT00897390 Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B) Status COMPLETED Phase PHASE1
NCT00894322 A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension Status COMPLETED Phase PHASE1/PHASE2
NCT00889668 Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device Status UNKNOWN Phase PHASE1/PHASE2
NCT00888238 A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179) Status COMPLETED Phase PHASE1
NCT00886574 Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events Status UNKNOWN Phase PHASE4
NCT00885378 Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00885352 Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) Status COMPLETED Phase PHASE3
NCT00877890 A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5) Status COMPLETED Phase PHASE3
NCT00874809 Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study Status COMPLETED Phase NA
NCT00870194 A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin Status COMPLETED Phase PHASE4